Last update:

Immunology news

Oncology & Cancer

Clinical trial: Some sarcoma patients improve with T cell immunotherapy

A clinical trial led by researchers at Washington University School of Medicine in St. Louis has shown that a T cell immunotherapy—in which the patients' own T cells are genetically modified to attack and kill cancer cells—is ...

Diseases, Conditions, Syndromes

COVID-19 antibody discovery could explain long COVID

UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the difficult acute effects of ...

Oncology & Cancer

Investigating mechanisms of aggressive glioblastoma tumor growth

Northwestern Medicine investigators have identified a metabolism-related gene that may play a role in recruiting immune cells to support the growth of aggressive brain tumors, according to a study recently published in Nature ...

Diseases, Conditions, Syndromes

Insights from patient who cleared hepatitis C could lead to vaccine

By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide with case numbers increasing every year.